For citations:
Klimenko A.A., Ivanov S.A., Dobrovol'skaya N.Yu. Long-term use of bevacizumab with interferon-alfa as a first-line targeted therapy of advanced kidney cancer. Malignant tumours. 2014;(2):37-42. (In Russ.) https://doi.org/10.18027/2224-5057-2014-2-37-42
Views PDF (Rus): 1563
Email this article 